The latest company updates, technical articles, and industry content.
Radiesse's Class III registration certificate in China gives the market a clearer regulatory benchmark for calcium hydroxyapatite filler products.
View Details
China's first approval for an injectable calcium hydroxyapatite microsphere facial filler sets a meaningful regulatory benchmark for the domestic aesthetics market.
View Details
Nanjing Junzhuo resumes the new year with continued focus on biomaterial R&D, hydroxyapatite microspheres, and long-term customer value.
View Details
Nanjing Junzhuo thanks customers and partners for moving through 2024 together and highlights continued progress in biomaterial innovation, global development, and future cooperation.
View Details
CaHA microspheres are becoming a stronger growth area in regenerative aesthetics as approvals expand, clinician familiarity improves, and demand shifts toward biostimulatory solutions.
View Details
Hyaluronic acid/hydroxyapatite composite hydrogels are being explored as a way to improve interface matching in bone-defect repair.
View Details